Notable Labs Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 31

Employees

  • Stock Symbol
  • NTBLQ

Stock Symbol

  • Investments
  • 1

Notable Labs General Information

Description

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.

Contact Information

Formerly Known As
StemCycle
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 320 Hatch Drive
  • Foster City, CA 94404
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Stock Exchange
PINX
Vertical(s)
Corporate Office
  • 320 Hatch Drive
  • Foster City, CA 94404
  • United States
+1 (415)

Notable Labs Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Notable Labs Stock Performance

As of 03-Jun-2025, Notable Labs’s current market cap is $966.00 with 9.7M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$966.00 9.7M 24.8K -$3.29

Notable Labs Financials Summary

As of 30-Jun-2024, Notable Labs has a trailing 12-month revenue of $313K.

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV (427) 56,257
Revenue 313 310 8 285
EBITDA (10,288) (11,007) (14,084) (15,725)
Net Income (10,542) (11,264) (14,407) (16,052)
Total Assets 11,004 19,541 5,511 8,488
Total Debt 1,795 2,049 361 1,843
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Notable Labs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Notable Labs‘s full profile, request access.

Request a free trial

Notable Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Notable Labs‘s full profile, request access.

Request a free trial

Notable Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patient
Drug Discovery
Foster City, CA
31 As of 2025

Boston, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Notable Labs Competitors (18)

One of Notable Labs’s 18 competitors is InSilico Medicine, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSilico Medicine Venture Capital-Backed Boston, MA
Verge Genomics Venture Capital-Backed South San Francisco, CA
OneThree Biotech Venture Capital-Backed New York, NY
Certis (Drug Discovery) Venture Capital-Backed San Diego, CA
AbCellera Biologics Formerly VC-backed Vancouver, Canada
You’re viewing 5 of 18 competitors. Get the full list »

Notable Labs Patents

Notable Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200046737-A1 Methods for treating cancer, and compositions therefor Inactive 09-Aug-2018

Notable Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Notable Labs Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Notable Labs‘s full profile, request access.

Request a free trial

Notable Labs Acquisitions (1)

Notable Labs’s most recent deal was a Merger/Acquisition with VBL Therapeutics for . The deal was made on 16-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
VBL Therapeutics 16-Oct-2023 Merger/Acquisition Biotechnology
To view Notable Labs’s complete acquisitions history, request access »

Notable Labs ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Notable Labs’s complete esg history, request access »

Notable Labs FAQs

  • When was Notable Labs founded?

    Notable Labs was founded in 2014.

  • Where is Notable Labs headquartered?

    Notable Labs is headquartered in Foster City, CA.

  • What is the size of Notable Labs?

    Notable Labs has 31 total employees.

  • What industry is Notable Labs in?

    Notable Labs’s primary industry is Drug Discovery.

  • Is Notable Labs a private or public company?

    Notable Labs is a Public company.

  • What is Notable Labs’s stock symbol?

    The ticker symbol for Notable Labs is NTBLQ.

  • What is the current market cap of Notable Labs?

    The current market capitalization of Notable Labs is $966.00.

  • What is Notable Labs’s current revenue?

    The trailing twelve month revenue for Notable Labs is $313K.

  • Who are Notable Labs’s competitors?

    InSilico Medicine, Verge Genomics, OneThree Biotech, Certis (Drug Discovery), and AbCellera Biologics are some of the 18 competitors of Notable Labs.

  • What is Notable Labs’s annual earnings per share (EPS)?

    Notable Labs’s EPS for 12 months was -$3.29.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »